Patients diagnosed with cancer in the U.S. during the first two years of the COVID-19 pandemic had significantly lower one-year cancer survival rates, leading to an estimated 17,390 more deaths than ...

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

Experts and interested parties are digging into the pharmacy benefit manager (PBM) reform provisions that were included in the massive spending bill that President Donald Trump signed into law on Feb ...

Drugs on TrumpRx will be listed from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer, which are the first five manufacturers to reach Most Favored Nation pricing deals with the Trump ...

Early managed care prioritized coordinated primary care “gatekeeping,” selective contracting, utilization/quality controls, ...

A meta-analysis of more than 20 phase 3 trials found no clear survival differences by sex or age in metastatic NSCLC but ...

Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and ...

Massachusetts is the top state for women’s health, according to a recent ranking of the best and worst states in America for ...

The funding legislation the House passed today that President Trump is expected to sign into law includes expansive changes ...

Cigna reported 11% revenue growth for 2025. Company executives focused on several key issues in its call with investors: its settlement with the Federal Trade Commission, a transformation announced ...

Preexposure prophylaxis (PrEP) is prescribed less to young women at an increased risk for HIV than to young men, according to the results of a study called ‘Differences in Sexual Health Clinic ...

Early menarche, late menopause, and long reproductive span increase ovarian cancer risk, particularly in postmenopausal women ...